This invention discloses an
esterase-responsive
nanogel-modified
bioprosthetic valve, its preparation method, and its application, belonging to the field of
bioprosthetic valve technology. This invention solves the problem of balancing the anti-infective properties,
biocompatibility, and
high surface modification rate of bioprosthetic valves. The invention uses ester-containing methacrylates and
antibiotic drugs as raw materials to synthesize
esterase-responsive monomers, then synthesizes
esterase-responsive nanogels, and then attaches them to the surface of the
bioprosthetic valve. Under
pathological conditions with high esterase concentrations, the ester bonds decompose, releasing the
antibiotic drugs in situ, thereby treating bacterial infections, reducing
inflammatory cell infiltration, and improving the anti-infective and anti-inflammatory properties of the bioprosthetic valve. Furthermore, the
nanogel contains a large number of hydrophilic groups, forming a hydration layer on the bioprosthetic valve surface, effectively reducing the risk of
thrombosis and coagulation, and resisting bacterial adhesion. The prepared bioprosthetic valve exhibits excellent anti-infective,
anticoagulant, anti-
calcification capabilities and stability.